Alpha DNA Investment Management’s Olin OLN Stock Holding History

Alpha DNA Investment Management’s Portfolio OLN Stock Details OLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-81	Closed	-$3K	–	468
2021 Q1	$3K	Buy	+81	New	+$2.46K	﹤0.01%	497

Other funds holding OLN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

RR Partners New York $929M AUM 110.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Alpha DNA Investment Management's OLN Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Olin (OLN) in Q2 2021, closing a stake of 81 shares — an estimated $3K sold.

Alpha DNA Investment Management first reported a position in OLN in Q1 2021 and held it in 1 quarter. The position peaked at $3K in Q1 2021. 360 funds tracked by Wall St. Rank hold OLN as of Q2 2021.

Alpha DNA Investment Management reported no remaining Olin position as of Q2 2021 after selling out during the quarter.
Alpha DNA Investment Management sold 81 Olin shares in Q2 2021, an estimated $3K.
Alpha DNA Investment Management first reported a position in Olin in Q1 2021 and held it in 1 quarter.
Alpha DNA Investment Management's Olin position peaked at $3K in Q1 2021.
360 funds tracked by Wall St. Rank held Olin as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.